Patient Selection Criteria for Qlosi™ for Presbyopia

Marjan Farid, MD

Show Description +

Marjan Farid, MD, reviews data from the NEAR-1 and NEAR-2 pivotal clinical trials for Qlosi™ (pilocarpine hydrochloride ophthalmic solution) 0.4% (Orasis Pharmaceuticals Inc.), demonstrating improvement in near vision without impacting distance. She also reviews the suitable criteria for selecting and identifying patients with presbyopia who can benefit from this treatment.

Posted: 7/30/2025

Up Next

Name: Patient Selection Criteria for Qlosi™ for Presbyopia
Uploaded: 2025-07-30T16:28:15+00:00
Description: Marjan Farid, MD, reviews data from the NEAR-1 and NEAR-2 pivotal clinical trials for Qlosi™ (pilocarpine hydrochloride ophthalmic solution) 0.4% (Orasis Pharmaceuticals Inc.), demonstrating improvement in near vision without impacting distance. She also reviews the suitable criteria for selecting and identifying patients with presbyopia who can benefit from this treatment.

A Unique Formulation for Presbyopia Treatment

Ben Gaddie, OD, FAAO

A Safe and Effective Solution for Presbyopia

Jessilin Quint, OD, MS, MBA, FAAO; and Marjan Farid, MD

Helping a Patient’s Presbyopia Journey

Jennifer Loh, MD

A Changing Treatment Landscape for Presbyopia

Sheri Rowen, MD

The Evolution of Presbyopia Treatment

Rishi P. Singh, MD

Medical Treatment for Presbyopia

Preeya Gupta, MD

Experts Discuss A Novel Presbyopia Therapeutic Option

John Berdahl, MD; Marjan Farid, MD; Preeya Gupta, MD; Edward Holland, MD; John Hovanesian, MD; Mitchell Jackson, MD; Jennifer Loh, MD

The Importance of Expanding Your Presbyopia Toolkit

John Berdahl, MD

Keeping Your Patients Engaged in the Presbyopia Conversation

Marjan Farid, MD

The Expanding Presbyopia Landscape

Preeya Gupta, MD

Addressing Presbyopia Patients' Unmet Needs

Edward Holland, MD

The Changing Landscape of Presbyopia Therapy

John Hovanesian, MD

Helping Your Patients Understand Presbyopia

Mitchell Jackson, MD

Maintaining and Growing your Presbyopic Patient Base

Jennifer Loh, MD

Near Vision Improvement Without Compromising Distance

Jessilin Quint, OD, MS, MBA, FAAO

Back to All Videos

Patient Selection Criteria for Qlosi™ for Presbyopia

Marjan Farid, MD

Posted: 7/30/2025

About Orasis Pharmaceuticals

ORASIS (OR-uh-sis) Pharmaceuticals is an emerging ophthalmic pharmaceutical company, with offices in the US and Israel, focused on developing an innovative solution for the treatment of presbyopia symptoms. Orasis’ novel proprietary formulation of low dose pilocarpine and a proprietary vehicle was purposefully designed with the patient in mind to achieve an optimal balance among efficacy, safety, and comfort.

The name Orasis has its roots in the Greek language, where it carries a literal translation of “good vision or sight.” Beyond this, however, as good vision in its positive mental/philosophical meaning — and this speaks to our aspiration as a company to develop pharmaceutical drugs that improve vision and quality of life for millions of people around the world.

Visit us online: orasis-pharma.com

Follow Orasis Pharmaceuticals